{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:33:46Z","timestamp":1768876426563,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Novo Nordisk Scandinavia AB, Malm\u00f6, Sweden"},{"name":"Novo Nordisk, Bagsv\u00e6rd, Denmark"},{"DOI":"10.13039\/501100006197","name":"The A.P. M\u00f8ller Foundation for the Advancement of Medical Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Initiative of Aarhus University Hospital"},{"name":"Aarhus University Hospital Skejby Research Foundation"},{"DOI":"10.13039\/501100003035","name":"Aase and Ejnar Danielsen Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Danish Prader-Willi Syndrome Association"},{"name":"The Augustinus Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ghir.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T02:38:21Z","timestamp":1308969501000},"page":"185-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome"],"prefix":"10.1016","volume":"21","author":[{"given":"Rasmus","family":"Sode-Carlsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stense","family":"Farholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai Fr.","family":"Rabben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Grethe","family":"Jurik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Sandahl","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"H\u00f6ybye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2011.05.002_bb0005","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1542\/peds.108.5.e92","article-title":"The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria","volume":"108","author":"Gunay-Aygun","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2011.05.002_bb0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1542\/peds.91.2.398","article-title":"Prader-Willi syndrome: consensus diagnostic criteria","volume":"91","author":"Holm","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2011.05.002_bb0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2011.05.002_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tem.2003.11.003","article-title":"Prader-Willi syndrome: advances in genetics, pathophysiology and treatment","volume":"15","author":"Goldstone","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0025","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/ajcn\/65.5.1369","article-title":"Peculiar body composition in patients with Prader\u2013Labhart-Willi syndrome","volume":"65","author":"Brambilla","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2011.05.002_bb0030","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/jcem.86.9.7814","article-title":"Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution","volume":"86","author":"Goldstone","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0035","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jcem.87.8.8735","article-title":"Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity","volume":"87","author":"Hoybye","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ghir.2009.12.004","article-title":"Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome","volume":"20","author":"Sode-Carlsen","year":"2010","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2011.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/oby.2006.193","article-title":"Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity","volume":"14","author":"Theodoro","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ghir.2011.05.002_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.ijo.0801175","article-title":"Activity related energy expenditure in children and adolescents with Prader-Willi syndrome","volume":"24","author":"van Mil","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ghir.2011.05.002_bb0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpeds.2004.01.056","article-title":"Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index\u2014a cross-sectional study","volume":"144","author":"Vestergaard","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2011.05.002_bb0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2265.2008.03228.x","article-title":"Randomized controlled growth hormone trial: Effects on anthropometry, body composition, and body proportions in a large group of children with Prader-Willi syndrome","volume":"69","author":"Festen","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2011.05.002_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mpd.2000.105369","article-title":"Sustained benefit after 2years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome","volume":"137","author":"Myers","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2011.05.002_bb0070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF03349255","article-title":"Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome","volume":"31","author":"Gondoni","year":"2008","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ghir.2011.05.002_bb0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1365-2265.2003.01769.x","article-title":"Growth hormone treatment improves body composition in adults with Prader-Willi syndrome","volume":"58","author":"Hoybye","year":"2003","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2011.05.002_bb0080","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1210\/jc.2007-2212","article-title":"Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial","volume":"93","author":"Mogul","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0085","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/jc.2010-0907","article-title":"One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study","volume":"95","author":"Sode-Carlsen","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1651-2227.2006.00051.x","article-title":"Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome","volume":"96","author":"Hoybye","year":"2007","journal-title":"Acta Paediatr."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2011.05.002_bb0095","first-page":"S43","article-title":"Diagnosis and classification of diabetes mellitus","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2011.05.002_bb0100","first-page":"169","article-title":"Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II","volume":"5","author":"Frystyk","year":"1995","journal-title":"Growth Regul."},{"key":"10.1016\/j.ghir.2011.05.002_bb0105","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s001250051561","article-title":"Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test","volume":"43","author":"Albareda","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2011.05.002_bb0110","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/diabetes.47.10.1643","article-title":"Prevalence of insulin resistance in metabolic disorders: the Bruneck Study","volume":"47","author":"Bonora","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2011.05.002_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone\u2013arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2011.05.002_bb0120","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2006-0600","article-title":"Conditional cardiovascular response to growth hormone therapy in adult patients with Prader-Willi syndrome","volume":"92","author":"Marzullo","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3476(95)70350-0","article-title":"Pulmonary function abnormalities in Prader-Willi syndrome","volume":"126","author":"Hakonarson","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2011.05.002_bb0130","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1210\/jc.2002-021536","article-title":"Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome","volume":"88","author":"Haqq","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0135","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s004310051246","article-title":"Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome","volume":"158","author":"Lindgren","year":"1999","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ghir.2011.05.002_bb0140","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/adc.2007.123836","article-title":"Scoliosis in Prader-Willi syndrome: prevalence, effects of age, gender, body mass index, lean body mass and genotype","volume":"93","author":"de Lind van Wijngaarden","year":"2008","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.ghir.2011.05.002_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000319709","article-title":"Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with prader-willi syndrome","volume":"75","author":"Colmenares","year":"2011","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2011.05.002_bb0150","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2008-1844","article-title":"Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome","volume":"94","author":"de Lind van Wijngaarden","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/jc.2002-021094","article-title":"The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval","volume":"88","author":"Darzy","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2011.05.002_bb0160","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2265.2006.02621.x","article-title":"Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome","volume":"65","author":"Grugni","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Suppl B","key":"10.1016\/j.ghir.2011.05.002_bb0165","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S1096-6374(00)80015-5","article-title":"Adult patients with Prader-Willi syndrome: clinical characteristics, life circumstances and growth hormone secretion","volume":"10","author":"Partsch","year":"2000","journal-title":"Growth Horm. IGF Res."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637411000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637411000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:46:56Z","timestamp":1761086816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637411000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1096637411000402"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2011.05.002","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2011.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}